
- Volume 0 0
 
Study Identifies Gene for Ovarian Cancer
An excess of the Rsf-1 gene may play an important role in the development of ovariancancer, based on an analysis of tissue from 7 ovarian cancer samples. Using a digital karyotypingtechnique to identify "subchromosomal alterations," the researchers observed anoverproduction of the Rsf-1 gene located on chromosome 11 in 13.2% of the most aggressiveforms of ovarian cancer. These results were not seen in any of the low-grade ovariancancers.
Because this was the first study to identify this genetic alteration, the new finding maylead to the development of a drug to block the activity of Rsf-1 and therefore stop the cancerouscell growth, concluded senior researcher Tian-Li Wang, PhD, in the Proceedings ofthe National Academy of Sciences (September 27, 2005).
Articles in this issue
about 20 years ago
COMPOUNDING HOTLINEabout 20 years ago
Compounding: Treating Mouth Ulcersabout 20 years ago
CAN YOU READTHESE Rxs?about 20 years ago
Do Pseudoephedrine Restrictions Reduce Meth Availability?about 20 years ago
RxWiseabout 20 years ago
Board May Discipline Pharmacy for Negligence of Pharmacistabout 20 years ago
AutoBoxabout 20 years ago
LucidLinkWireless Securityabout 20 years ago
MILT 2.0about 20 years ago
PACMEDNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.














































































































































































































